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Abstract: Gene conversion is a specific type of homologous recombination that involves 
the unidirectional transfer of genetic material from a ‘donor’ sequence to a highly 
homologous ‘acceptor’. We have recently reviewed the molecular mechanisms underlying 
gene conversion, explored the key part that this process has played in fashioning extant 
human genes, and performed a meta-analysis of gene-conversion events known to have 
caused human genetic disease. Here we shall briefly summarize some of the latest 
developments in the study of pathogenic gene conversion events, including (i) the 
emerging idea of minimal efficient sequence homology (MESH) for homologous 
recombination, (ii) the local DNA sequence features that appear to predispose to gene 
conversion, (iii) a mechanistic comparison of gene conversion and transient 
hypermutability, and (iv) recently reported examples of pathogenic gene conversion 
events. 
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1. Introduction 
Gene conversion refers to the unidirectional transfer of genetic material from a ‘donor’ sequence to 
a highly homologous ‘acceptor’. It is one of four pathways of homologous recombination, the other 
three being non-allelic homologous recombination (NAHR), break-induced replication (BIR) and 
single-strand annealing (SSA) (Figure 1). All pathways share a similar initiating event: The  
double-strand break (DSB) generated within one of the duplicated (or repeated) sequences undergoes 
extensive 5'-end resection to form 3' single-stranded DNA tails. Gene conversion, NAHR and SSA all 
serve to repair DSBs with two ends, whereas BIR repairs DSBs with only one end. Gene conversion 
and NAHR may be considered to represent alternative outcomes of a common two-ended DSB repair 
process (for detailed description, see [1]). 
In a recent review article, we assessed the current thinking in relation to the molecular mechanisms 
underlying gene conversion, surveyed the impact of gene conversion on human genome evolution, and 
performed a meta-analysis of pathogenic gene conversion events [2]. In this article, we shall briefly 
summarize some of the latest advances in the study of pathogenic gene conversion events. 
2. The Emerging Idea of Minimal Efficient Sequence Homology for Homologous Recombination 
Homologous recombination is one of the major mechanisms for the repair of DSBs (the other is 
non-homologous end joining [1]). As the term implies, homologous recombination is mediated through 
sequences which exhibit considerable similarity that presumably serves to stabilize chromosomal 
mispairing. In this regard, it is pertinent to note that the rate of gene conversion is directly proportional 
to the length of the uninterrupted sequence tract in the putatively converted region: in mouse cells, the 
minimal efficient processing segment (MEPS) for efficient meiotic homologous recombination is 
>200 bp [3–4] while in humans, it is estimated to be in the range of 337–456 bp [5].  
How extensive does the global sequence similarity need to be for efficient homologous 
recombination to occur between two interacting sequences? Our analysis of 44 interlocus pathogenic 
gene conversion events revealed that the similarity between the interacting sequences is almost 
invariably >92% [2]. This finding has recently received strong support from the results of a study that 
approached this issue from an evolutionary perspective [6]. Both the human and chimpanzee growth 
hormone gene (GH1 in humans and GHN in chimpanzee) promoters are highly polymorphic, and all 
14 human GH1 promoter SNPs and five of the nine chimpanzee GHN promoter SNPs could potentially 
have resulted from interlocus gene conversion (i.e., the minor allele occurs in at least one of the  
cis-linked paralogous genes); by contrast, no polymorphism was evident in the macaque GH1 gene 
promoter. Remarkably, the mean degree of pair-wise similarity between the GH1 promoter and its 
paralogs in macaque is 92.0%, significantly lower than in either chimpanzee (93.5%) or human 
(94.0%). Thus, it appears that if the degree of similarity between related gene sequences falls below a 
certain threshold (perhaps around 92%), then gene conversion may be significantly reduced or even 
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abolished, with attendant consequences for the genetic variability manifested by the sequences 
in question [6]. 
Figure 1. Mutational models of homologous recombination. In the models of gene 
conversion, NAHR (non-allelic homologous recombination) and BIR (break-induced 
replication), the invading strand invariably binds to a homologous sequence. In the model 
of SSA (single-strand annealing), the black bars indicate the direct repeats that flank a DSB 
(double-strand break). In the dissolution model of gene conversion, the two facing 
horizontal purple arrows indicate convergent branch migration. In the double HJs 
(Holliday junctions) cleavage model of gene conversion, the four horizontal green arrows 
indicate the orientation of resolution. In the double HJ cleavage model of NAHR, the dHJs 
can be cleaved as indicated by the green arrows or by the red arrows. In the model of BIR, 
the invading strand may undergo multiple rounds of displacement and annealing (indicated 
by dotted arrows) before a stable replication structure is established; this probably reflects 
repeated attempts to find the other end of the DSB. D-loop, displacement loop; RF, 
replication fork; SDSA, synthesis-dependent strand annealing. Reprinted from [1]. 
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By analogy to the concept of MEPS, we have proposed that efficient homologous recombination 
(including gene conversion) may also require a minimal efficient sequence homology (MESH; 
approximately 92%) between the interacting sequences [7]. Further supporting evidence for this idea 
has come from the accurate estimation of copy number variation and multicopy gene number in 159 
human genomes; signatures consistent with gene conversion were virtually exclusive to high-identity 
duplications (>95% sequence similarity) and tended to occur in association with tandem duplications 
(≤1 Mbp) [8]. 
In summary, whereas the concept of MEPS defines a local sequence property of homologous 
recombination, MESH defines a global sequence property of homologous recombination.  
3. Local Sequence Features Predisposing to Gene Conversion 
A variety of DNA sequences, including direct repeats, inverted repeats (sometimes incorrectly 
termed palindromes), minisatellite repeats, the  recombination hotspot, and alternating  
purine–pyrimidine tracts with Z-DNA-forming potential, have frequently been noted in association 
with gene conversion in human genes (see references in [9]). In addition, the convergence of 
biochemical, genetic, and genomic studies in the context of gross genomic deletions, inversions, 
duplications, and translocations has suggested that the ability of a given DNA sequence to adopt a  
non-B DNA conformation (e.g., slipped structures, triplexes and tetraplexes), rather than the DNA 
sequence per se (in the orthodox right-handed Watson-Crick B-form), could induce chromosomal 
DSBs (reviewed in [10]). However, no methodical statistically based analysis had been performed to 
formalize these observations until recently, when a series of well-characterized human gene 
conversion mutations were employed as a test system. The advantage of this novel approach lay in the 
fact that the extents of the maximal converted tracts (MaxCTs) and minimal converted tracts (MinCTs) 
associated with such pathological events could usually be fairly accurately determined and  
annotated [9]. In silico analysis of the DNA sequence tracts involved in 27 nonoverlapping pathogenic 
gene conversion events in 19 different genes yielded several novel findings [9]. First, gene conversion 
events tend to occur preferentially within (C + G)- and CpG-rich regions. Second, sequences with the 
potential to form non-B DNA structures occur disproportionately within MaxCTs and/or short flanking 
regions. Third, MaxCTs are enriched (P < 0.01) in a truncated version of the  element (a TGGTGG 
motif), immunoglobulin heavy chain class switch repeats, translin target sites and several novel motifs 
including (or overlapping) the classical meiotic recombination hotspot, CCTCCCCT. Finally, gene 
conversions tend to occur in genomic regions that have the potential to fold into stable hairpin 
conformations [9]. These findings therefore provide support for the concept that recombination-
inducing motifs, in association with alternative DNA conformations, can promote recombination in the 
human genome. 
The importance of non-B DNA conformations in predisposing genomic rearrangements is perhaps 
best exemplified by a rather unique case of gene conversion. Soejima and colleagues reported a  
Sec1-FUT2-Sec1 hybrid allele that apparently resulted from a gene conversion event [11]. As pointed 
out by these authors, this allele is more appropriately termed Sec1-Se428-Sec1 because it is the Se428 
mutant allele of the FUT2 gene that acts as the donor sequence (Figure 2). Interestingly, the 5' half of 
the MaxCT of this interlocus gene conversion event overlaps with the crossover region of the 
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previously reported Sefus mutant allele (Figure 2). The Sefus allele was generated by NAHR via a 
process through which the 3'-part of the FUT2 gene was fused to the 5'-part of the Sec1 gene [12]. 
Based on our current understanding of mutational mechanisms, we reasoned that the initiating DSBs 
leading to the Sec1-Se428-Sec1 and Sefus alleles might have occurred within the aforementioned 
overlapping sequence tract. 
Figure 2. Partial sequence alignment of the Sec1 gene, the FUT2 gene and the Se428 mutant 
allele of the FUT2 gene. Dashes indicate identity with Sec1 DNA sequence. Nucleotides 
are numbered in accordance with previous publications (e.g., [11]) for easy comparison; 
numbers above the aligned sequences refer to Sec1 sequence whereas those below the 
aligned sequences refer to both FUT2 and Se428 sequences. As compared with the  
wild-type FUT2 gene, the Se428 mutant allele contains the 428G > A nonsense mutation 
and the 216C > T polymorphism. Sequence between the two vertical continued bars 
indicates the crossover region of the non-allelic homologous recombination-derived Sefus 
allele, in which the 3'-part of the FUT2 gene was fused to the 5'-part of the Sec1 gene. 
Shaded sequences indicated the maximal converted tract (MaxCT) of the gene  
conversion-derived Sec1-Se428-Sec1 allele (Sec1 is the acceptor gene whilst Se428 is the 
donor gene). The overlapping sequence tract between the MaxCT of the Sec1-Se428-Sec1 
allele and the crossover region of the Sefus allele spans positions 259 to 416 in the context 
of the Sec1 sequence. Reprinted from [13]. 
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We further reasoned that, were this to be the case, the overlapping sequence tract might be capable 
of adopting non-B conformation(s) [13]. Indeed, upon inspection, four GGG repeats within the 
overlapping sequence tract were identified that would appear to have the potential to fold into a 
tetraplex structure (Figure 3a). In addition, by means of a previously established method for predicting 
the ‘local’ secondary structure of nucleotide sequences [14], we identified a hairpin structure that can 
potentially be formed by a specific pair of imperfect inverted repeats (Figure 3b). We speculate that 
these non-B DNA structures may have acted either individually or synergistically to promote the 
formation of DSBs, which in turn could have initiated the process of homologous recombination [13]. 
Figure 3. Non-B conformations identified within the overlapping sequence tract between 
the maximal converted tract (MaxCT) of the Sec1-Se428-Sec1 allele and the crossover 
region of the Sefus allele (refer to Figure 2). (a) A tetraplex structure formed by four GGG 
repeats. The sequence illustrated corresponds to the reverse complement of Sec1 spanning 
positions 296 to 344 (see Figure 2); (b) A hairpin structure formed by a pair of imperfect 
inverted repeats. The sequence illustrated corresponds to Sec1 spanning positions 260 to 
304 (see Figure 2). Reprinted from [13]. 
 
 
4. Gene Conversion vs Transient Hypermutability: A Mechanistic Comparison 
Data from a wide variety of organisms (including viruses, prokaryotes and yeast, as well as cell 
lines and tissues from higher eukaryotes) have clearly demonstrated that the number of instances of 
multiple mutation is significantly higher than would be predicted simply from the mutation frequency 
and a random distribution of mutations [15]. For example, some of the multiple somatic HPRT 
mutations detected in a human epithelial cell line were closely spaced, with 4/12 mutation pairs being 
separated by only 6 bp on average, a much higher proportion than would be expected by chance  
Genes 2010, 1             
 
 
556
alone [16]. The most robust data came from studies employing the Big Blue® transgenic mouse 
system [17–18]; complete sequencing of the 1.4 kb lacI transgene in thousands of mouse mutants from 
normal tissues and spontaneous tumors demonstrated that the distribution of the spacing between 
component mutations in doublets (two spatially separated mutations identified in cis) was highly  
non-random, with half the doublets being separated by <120 bp [18].  
‘Multiple mutations’ can in principle be the observable net result of the sequential accumulation of 
single mutations independently generated during multiple cell replications (Figure 4a). However, 
known examples of such mutations [19,20] exhibit an essentially random inter-component spacing 
distribution, as would be expected for mutations of independent origin [15,21]. Consequently, the 
multiple mutations that exhibit non-random proximal spacing in higher eukaryotes [16,18]—termed 
‘closely spaced multiple mutations’ (CSMMs; [22])—are most compatible with a model in which they 
are generated simultaneously or quasi-simultaneously in the same cell cycle (Figure 4b). Multiple 
synchronous mutations have been postulated to arise via transient hypermutability resulting from  
(i) the deregulated expression of, or conformational change in, either a replicative DNA polymerase or 
another protein involved in the maintenance of replication fidelity, (ii) the disruption of the balance of 
the nucleotide pool, or (iii) the recruitment of error-prone DNA polymerases in DNA replication or 
repair [15,23,24].  
Figure 4. Two concepts for generating multiple mutations. Multiple mutations can 
accumulate during multiple cell cycles (a) or can be generated in the same cell cycle and in 
rapid succession (b). Adapted from [22]. 
 
 
Recently, we have extended the concept of transient hypermutability from somatic cells to the 
germline, using human inherited disease-causing multiple mutations as a model system. Employing 
stringent criteria for data inclusion, we retrospectively identified 151 potential examples of pathogenic 
CSMMs [22]. Taken at face value, these examples possessed at least three features which were 
consistent with those noted with the Big Blue® transgenic mouse system [17,18]. First, a large fraction 
of the multiple mutations were closely spaced. Second, some single nucleotide substitutions (SNS) 
were found to coexist with other types of mutation. Finally, a small fraction of the collected multiple 
mutations comprised three or more distinct components. In particular, eight multiple mutations 
comprised three or more components within a sequence tract of <100 bp. The majority of these 
mutations may reasonably be assumed to have occurred as simultaneous or quasi-simultaneous events, 
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thereby providing the first evidence to support the contention that the human germline can also 
experience transient hypermutability [22]. 
We then sought to procure evidence to support the postulate that the closely spaced double 
mutations causing human inherited disease arose predominantly through transient hypermutability. For 
reasons of simplicity, we focused our attention upon the 102 disease-causing double mutations that 
comprise exclusively SNS mutations. Transient hypermutability has been postulated to result from 
three different mechanisms (see before), all of which imply new DNA synthesis. One mutational 
mechanism which does not involve new DNA synthesis is methylation-mediated deamination of  
5-methylcytosine, which gives rise to C > T transitions (or G > A transitions on the complementary 
strand). Since 5-methylcytosine in the human genome is almost exclusively confined to the CpG 
dinucleotide, this mechanism accounts for the CpG dinucleotide being a mutation hotspot. We 
therefore surmised that the proportion of CpG substitution, manifested by the component mutations 
from a given set of multiple mutations, could be used as a crude indicator of the relative likelihood of 
transient hypermutability: the lower the proportion of CpG substitution, the higher the likelihood that 
the multiple mutations would have arisen via transient hypermutability [22].  
Figure 5. CpG substitutions in double single nucleotide substitution (SNS) mutations.  
(a) Top panel illustrates the distribution of CpG substitutions in 102 pathogenic double 
SNS mutations. Each pair of vertical circles indicates a double SNS mutation. The upper 
and lower circles indicate the first and second components of a given double mutation, 
respectively. Solid circles indicate CpG substitutions. The lower panel compares the 
proportion of CpG substitutions in the group of ≤100 bp with that in the group of >100 bp; 
(b) Proportion of CpG substitutions in the group of ≤100 bp with that in the group of  
>100 bp; data were derived from a re-analysis of all double SNS mutations obtained from 
the Big Blue mice [17,18]. Reprinted from [22].  
 
 
The 102 double SNS mutations could be roughly divided into three groups on the basis of the 
relative proportion of CpG substitution (top panel, Figure 5a). The first group comprised 58 events 
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with an inter-component distance of 1–95 bp, and had the lowest proportion of CpG substitution 
(10%). The second group comprised 10 events with an inter-component distance of 103–462 bp, with 
an intermediate CpG substitution rate of 30.0%. The third group, comprising the remaining 34 events 
with an inter-component distance of 501–309,408 bp, exhibited the highest CpG substitution  
rate (50%). This distribution pattern coincided with two observations made in the Big Blue transgenic 
mice: first, nearly all the observed doublets were separated by an intervening sequence of <500 bp; 
second, it was those doublets with an inter-component distance of 1–100 bp that occurred more 
frequently than would be expected for independent mutations [18]. Adopting a fairly conservative 
strategy, we used the cutoff value of ≤100 bp to define CSMMs in the human context, manifesting a 
CpG substitution rate of 10%, significantly lower than that the 45% which characterized the remaining 
44 double SNS events of >100 bp (lower panel, Figure 5a). Employing the same standard, we also 
revisited the double SNS mutations reported by Buettner et al. [17] and Hill et al. [18] and derived a P 
value of marginal significance: CpG substitution rates were 13% for the 19 events of ≤100 bp and 32% 
for the 19 events of >100 bp (Figure 5b). 
The aforementioned findings strongly suggest that the two groups of double SNS mutations  
(i.e., ≤100 bp and >100 bp) arose via qualitatively quite different mutational mechanisms. This 
postulate was then given further support from the analysis of the highly informative homocoordinate 
mutations (multiple mutations in the same gene involving the same mutation type but occurring at 
different sites in cis [18]). Of the 102 double SNS mutations causing inherited disease, 17 were found 
to be homocoordinate mutations. Again, qualitative differences were apparent between the two groups 
of homocoordinate mutations. Only one of the six homocoordinate events in the ≤100 bp group 
involved a CpG substitution. By contrast, 10 of the 11 homocoordinate events in the >100 bp group 
were characterized by CpG substitutions [22]. 
Taking these data together, we proposed that CSMMs comprising at least one pair of mutations 
separated by ≤100 bp may constitute signatures of transient hypermutability in human genes [22]. Here 
it should however be emphasized that gene conversion events (with the exception of those that induce 
only a single nucleotide change) constitute in effect an important type of multiple mutation. They are 
also thought to be generated simultaneously or quasi-simultaneously in the same cell cycle; moreover, 
their MaxCTs are usually short, rarely exceeding 1 kb [2]. Mechanistically, there is a qualitative 
difference between these gene conversion events and multiple mutations originating via transient 
hypermutability. Whereas gene conversion constitutes a template-switching event through which a 
highly homologous template is faithfully copied by a normal replicative DNA polymerase, transient 
hypermutability-mediated multiple mutations are due to misincorporation of bases during DNA 
replication or repair. 
5. New Examples of Pathogenic Gene Conversion Events 
We initially collated 44 interlocus gene-conversion events (involving a total of 17 genes) that are 
known to have given rise to human inherited disease (see Table 1 in [2]). In the process of collating 
examples of multiple mutations that could have arisen through transient hypermutability [22], we 
identified eight further gene conversion mutations, all of which were included in our subsequent 
in silico analysis of the local sequence features that might predispose to gene conversion [9]. Here it is 
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important to emphasize that all of these gene conversion events were collected in accordance with 
fairly stringent selection criteria. For example, all reported gene-conversion events comprising only a 
single nucleotide substitution were omitted from the analysis, since the possibility that these changes 
may have originated by simple point mutation can never be excluded. In addition, all gene conversion 
events that were not fully characterized at the nucleotide sequence level were also excluded [2]. Our 
collation therefore represents only a fraction of the actual number of pathogenic gene conversion 
events already described in one form or another in the literature. Hence, these collated data allow only 
a very conservative estimate to be made of the likely relative frequency of gene conversion as a cause 
of human inherited disease.  
In a just published report, Boria and colleagues investigated the possible occurrence of  
pseudogene-mediated gene conversion in Diamond-Blackfan anemia (DBA) [25]. Mutations in nine 
ribosomal protein (RP) genes have so far been reported in ~50% of DBA patients. They aligned 
sequences of the most frequently mutated RP genes (i.e., RPS19, RPL5 and RPL11) with their 
respective pseudogene sequences and looked at 5 bp on each side of the mutation; coincidence was 
found in six mutations (Table 1). Evidently, they “could not exclude that the same changes arose 
independently in the gene and in the pseudogene” [25]. Here we would like to add that (i) both micro-
deletions occurred within short direct repeats (three A and two AGAC, respectively) such that they are 
explicable by the classical model of replication slippage, a subclass of the recently coined 
“microhomology-mediated replication-dependent recombination (MMRDR)” mechanism [1], and 
(ii) three (i.e., c.403G > A, c.166C > T, and c.535C > T) of the four SNS mutations are CpG 
substitutions. By contrast, the c.191T > C mutation did not occur within a known mutational hotspot 
and thus may have a higher probability of being generated by gene conversion. 
Table 1. Six ribosomal protein (RP) mutations found to coincide with pseudogene sequences. 
Gene 
(Chromosomal 
Localization) 
Mutation Wild-Type Sequence Pseudogene 
Sequences 
Pseudogene 
(Chromosomal 
Localization) 
RPS19 (19q13.2) c.384_385delAA GGACAAAGAGAT GGACA--GAGAT RPS19P2 (1p13.2) 
 c.403G > A GAATCGCCGGA GAATCACCGGA RPS19P2 (1p13.2) 
 c.191T > C GCACCTGTACC GCACCCGTACC RPS19P4 (5q11.2) 
 c.166C > T ACACGCGAGCT ACACGTGAGCT RPS19P7 (10q11.21) 
RPL5 (1p22.1) c.535C > T CCAAACGATTC CCAAATGATTC RPL5P34 (22q13.2) 
RPL11 (1p36.1-p35) c.94_97delAGAC GAGACAGACTGAG GAGAC----TGACG RPL11P5 (12q24.31) 
* From [25] 
In certain cases, gene conversion is nevertheless more plausible than simple point mutation as an 
explanation for the observed single nucleotide changes. For example, Moradkhani et al. identified 14 
different human hemoglobin (Hb) variants resulting from identical mutations on either one of the two 
human -globin paralogous genes (HBA1 and HBA2) [26]. Interallelic gene conversion was regarded 
as the most plausible mechanism to account for “the same mutation being ‘transferred’ into different 
genomic contexts”. In support of this postulate is the fact that 13 out of the 14 Hb variants were 
located within exons 1 and 2; these two exons (but not exon 3) have been previously shown to be 
involved in gene conversion events [26]. Another example is provided by the identification of high 
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frequency sequence exchange events between PMS2 and its pseudogene, PMS2CL, in which gene 
conversion has certainly played a key role [27].  
Recently, Gardner et al. [28] reported a pathogenic gene conversion mutation that satisfies our 
previously established stringent selection criteria [2]. In a family with X-linked cone and cone-rod 
dystrophies, a missense mutation (c. 529T > C [p. W177R]) in exon 3 of both the long-wavelength-
sensitive and medium-wavelength-sensitive cone opsin genes (OPN1LW and OPN1MW) was found to 
segregate with the disease. As opined by Gardner et al., the spontaneous occurrence of this point 
mutation in both genes is most unlikely. Much more likely was that the mutation first originated in one 
gene and was then transferred to the other by a gene conversion event. Indeed, the mutation in the 
OPN1LW gene was found to be embedded within a block of OPN1MW sequence [28] (a gene 
conversion mutation involving OPN1LW and OPN1MW was previously reported to cause blue cone 
monochromacy [29]). This new gene conversion event and the eight events described in  
Chuzhanova et al. [9] are summarized in Table 2. Additionally, a putative double gene conversion 
event causing spinal muscular atrophy has also been reported [30].  
Table 2. Recently collated examples of interlocus gene conversion events. 
Disease/Phenotype 
Donor 
Gene 
Acceptor 
Gene 
Chromosomal 
Localization 
Mutation Ref. 
Congenital adrenal hyperplasia CYP21A1P CYP21A2 6p21.3 Intron 2 conversion [31] 
Increased CYP3A7 expression in 
adult liver and intestine 
CYP3A4 CYP3A7 7q21-q22.1 Promoter conversion [32] 
Novel St glycophorin GYPE GYPA 4q28-q31 GPA-E-A hybrid gene [33] 
Microcytosis HBA2 HBA1 16p13.3 α121 patchwork [34] 
Agammaglobulinemia IGLL3 IGLL1 22q11.23 Conversion of exon 2 [35] 
Sec1–FUT2–Sec1 hybrid allele FUT2 Sec1 19q13.3 
Conversion involving 
exonic sequence 
[11] 
Atypical hemolytic uremic 
syndrome 
CR1L CD46 1q32 D151N + Y155D [36] 
Pachyonychia congenita type 2 KRT17P3 KRT17 17q21.2 452G > A and 457T > C [37] 
X-linked cone and cone-rod 
dystrophies 
OPN1MW OPN1LW Xq28 c. 529T > C [p. W177R] [28] 
* Collated after the publication of [2]; the first eight entries have been previously described in [9]. 
6. Conclusions 
Further gene conversion mutations causing human inherited disease will continue to be identified in 
the future and these should contribute to our emerging understanding of this important mutational 
mechanism. Indeed, the identification and analysis of such naturally occurring gene conversion events 
will serve as an invaluable source for refining the general characteristics of gene conversion in 
particular and homologous recombination in general. Although, to date, most relevant research has 
focused on the study of germline mutations, we speculate that somatic mosaicism resulting from 
interallelic gene conversion, which has until now largely escaped our attention, could turn out to be a 
potentially new and important modifier of human inherited disease [2]. Finally, it is pertinent to 
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mention that an artificial form of gene conversion, brought about by means of homing endonucleases, 
holds great promise for targeted gene therapy in patients with monogenic diseases (reviewed in [38]). 
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